文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

COVID-19与H1N1流感所致ARDS之间的代谢组学差异

Metabolomic diferences between COVID-19 and H1N1 influenza induced ARDS.
PubMed 文献 · Crit Care · 2021-11-15
一句话结论COVID-19与H1N1流感所致ARDS的血清代谢组学特征不同,分类模型区分病因成功率达100%。

研究纳入ICU中18例COVID-19相关ARDS与20例甲型流感肺炎(IAP)相关ARDS患者,ARDS按美欧共识会议定义,采用核磁共振波谱分析血清样本,多变量统计分析识别组间代谢差异并进行代谢通路分析。结果显示两组在氨基酸代谢、脂质代谢、糖酵解和回补代谢方面调控不同;COVID-19引起显著能量供应不足并诱导补充产能通路,而IAP患者炎症与氧化应激反应更明显;分类模型区分肺炎病因的成功率为100%。作者认为ARDS具有特征性代谢组学特征,可能区分不同病因的ARDS,并可能成为诊断、预后和管理的潜在生物标志物。

要点

  • 18例COVID-19相关ARDS与20例IAP相关ARDS患者血清核磁共振波谱分析显示,两组氨基酸代谢、脂质代谢、糖酵解和回补代谢调控不同。
  • COVID-19相关ARDS引起显著能量供应不足并诱导补充产能通路;IAP相关ARDS患者炎症与氧化应激反应更明显。
  • 代谢组学分类模型区分肺炎病因的成功率为100%。
  • 与COVID-19患者相比,IAP患者更年轻,且更常使用去甲肾上腺素维持平均动脉压>65 mm Hg。
  • 作者认为ARDS的特征性代谢组学特征可能成为诊断、预后和管理的潜在生物标志物。

适用人群与场景

  • ICU收治的ARDS患者:18例COVID-19相关ARDS与20例甲型流感肺炎(IAP)相关ARDS。
  • ARDS按美欧共识会议(American-European Consensus Conference)定义。

诊断标准与关键阈值

  • ARDS诊断采用美欧共识会议定义。

处置流程与药物剂量

  • 与COVID-19患者相比,IAP患者更常使用去甲肾上腺素维持平均动脉压>65 mm Hg。

研究设计与关键结果

  • 研究类型为代谢组学病例对照研究,纳入ICU中18例COVID-19相关ARDS与20例IAP相关ARDS患者,采用核磁共振波谱分析血清样本,多变量统计分析识别组间代谢差异。
  • COVID-19与IAP所致ARDS在氨基酸代谢、脂质代谢、糖酵解和回补代谢方面调控不同。
  • COVID-19相关ARDS引起显著能量供应不足并诱导补充产能通路;IAP相关ARDS患者炎症与氧化应激反应更明显。
  • 代谢组学分类模型区分肺炎病因的成功率为100%。
  • 与COVID-19患者相比,IAP患者更年轻,且更常使用去甲肾上腺素维持平均动脉压>65 mm Hg。

证据类型、等级与局限

  • 证据类型:代谢组学病例对照研究(血清核磁共振波谱分析)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为ARDS的特征性代谢组学特征可能区分不同病因的ARDS,并可能成为该病诊断、预后和管理的潜在生物标志物。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Acute respiratory distress syndrome (ARDS) is a type of respiratory failure characterized by lung inflammation and pulmonary edema. Coronavirus disease 2019 (COVID-19) is associated with ARDS in the more severe cases. This study aimed to compare the specificity of the metabolic alterations induced by COVID-19 or Influenza A pneumonia (IAP) in ARDS.

METHODS: Eighteen patients with ARDS due to COVID-19 and twenty patients with ARDS due to IAP, admitted to the intensive care unit. ARDS was defined as in the American-European Consensus Conference. As compared with patients with COVID-19, patients with IAP were younger and received more often noradrenaline to maintain a mean arterial pressure > 65 mm Hg. Serum samples were analyzed by Nuclear Magnetic Resonance Spectroscopy. Multivariate Statistical Analyses were used to identify metabolic differences between groups. Metabolic pathway analysis was performed to identify the most relevant pathways involved in ARDS development.

RESULTS: ARDS due to COVID-19 or to IAP induces a different regulation of amino acids metabolism, lipid metabolism, glycolysis, and anaplerotic metabolism. COVID-19 causes a significant energy supply deficit that induces supplementary energy-generating pathways. In contrast, IAP patients suffer more marked inflammatory and oxidative stress responses. The classificatory model discriminated against the cause of pneumonia with a success rate of 100%.

CONCLUSIONS: Our findings support the concept that ARDS is associated with a characteristic metabolomic profile that may discriminate patients with ARDS of different etiologies, being a potential biomarker for the diagnosis, prognosis, and management of this condition.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Lorente JA, Nin N, Villa P, et al. Metabolomic diferences between COVID-19 and H1N1 influenza induced ARDS. Crit Care. 2021. PMID: 34781986. doi:10.1186/s13054-021-03810-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。